Company: APXIF
Filing Date: 2025-03-31
Form Type: F-4/A
Source: 0001213900-25-026339
Chunk: 386

Company: APx Acquisition Corp. I
Filing Date: 2025-03-31
Form: F-4/A
Chunk 386
---
 decrease. Additionally, CIBIC will not participate in sales of our Heritas Diagnostic and Rewell products in countries other than Argentina. Other funding sources will include: Rewell in Argentina (business to consumer or business -to -business); Diagnostics and Rewell in other countries. The distribution model reduces the risks associated with product market entry (both commercial and regulatory) in each country and, in parallel, allows exclusive distribution to be anchored to a business plan that the distributor must meet, minimizing the initial risk of operations in each country. In addition, we receive payments from a variety of sources, including patients, biopharmaceutical partners, third -partypayers, and other business -to -businesscustomers. We rely on sales that occur through private channels and from social security. We believe that our performance and future success depends on several factors that present significant opportunities for growth but also pose risks and challenges, including those in the section of this proxy statement/prospectus entitled “ Risk Factors — Risks Related to Our Business and Industry.” Human Capital Resources People and Diversity The strength of our team and the culture in which they work is essential to our ability to achieve our broader mission. As such, we seek to attract and retain top tier talent and provide them the opportunity to develop along with the company. Our human capital is dedicated to enhancing individual development and nurturing a culture of collaboration and unity within our teams. We foster a community filled with people from various disciplines, including science, medicine, data science, entrepreneurship, business, marketing, and sales. This multifaceted team is not only diverse in expertise but also in geography, with dedicated professionals hailing from Argentina, Peru, and Portugal, further enriching our culture with a variety of perspectives and experiences, which further adds to our talent development. 200 As of the date hereof, we have 25 employees, of which approximately 83% identified as women, highlighting our commitment to inclusivity and gender diversity within our dynamic team. Culture Our culture is driven to make a difference for health management, striving to be a model of excellence within the healthcare industry. The team is defined by the drive to collaborate effectively, creating a workplace that fosters innovation and attracts, nurtures, and retains a diverse and talented workforce. Our approach to culture, engagement, and change management is proactive and aligned with our overarching business goals. We are dedicated to creating an environment that champions creativity, promotes professional growth, and supports employees as they achieve both scientific and personal milestones. This philosophy is ingrained in every facet